NASDAQ:DRAD - Digirad Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.64 -0.01 (-1.53 %) (As of 05/19/2019 10:28 AM ET)Previous Close$0.6448Today's Range$0.63 - $0.683452-Week Range$0.42 - $1.95Volume42,632 shsAverage Volume87,795 shsMarket Capitalization$13.10 millionP/E RatioN/ADividend Yield8.53%Beta2.37 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services. The Mobile Healthcare segment offers contract diagnostic imaging services, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment develops and sells gamma camera imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance services. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia. Receive DRAD News and Ratings via Email Sign-up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DRAD Previous Symbol CUSIPN/A CIK707388 Webwww.digirad.com Phone858-726-1600Debt Debt-to-Equity Ratio0.62 Current Ratio1.59 Quick Ratio1.18Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$104.18 million Price / Sales0.13 Cash Flow$0.3208 per share Price / Cash Flow2.01 Book Value$1.19 per share Price / Book0.54Profitability EPS (Most Recent Fiscal Year)N/A Net Income$740,000.00 Net Margins-4.90% Return on Equity-9.16% Return on Assets-4.49%Miscellaneous Employees452 Outstanding Shares20,310,000Market Cap$13.10 million Next Earnings Date8/1/2019 (Estimated) OptionableOptionable Digirad (NASDAQ:DRAD) Frequently Asked Questions What is Digirad's stock symbol? Digirad trades on the NASDAQ under the ticker symbol "DRAD." How often does Digirad pay dividends? What is the dividend yield for Digirad? Digirad announced a quarterly dividend on Friday, August 3rd. Stockholders of record on Thursday, August 16th will be paid a dividend of $0.055 per share on Thursday, August 30th. This represents a $0.22 annualized dividend and a dividend yield of 34.12%. The ex-dividend date is Wednesday, August 15th. View Digirad's Dividend History. How were Digirad's earnings last quarter? Digirad Co. (NASDAQ:DRAD) issued its quarterly earnings data on Friday, May, 3rd. The medical equipment provider reported ($0.05) EPS for the quarter. The medical equipment provider had revenue of $23.91 million for the quarter. Digirad had a negative return on equity of 9.16% and a negative net margin of 4.90%. View Digirad's Earnings History. When is Digirad's next earnings date? Digirad is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for Digirad. What guidance has Digirad issued on next quarter's earnings? Digirad issued an update on its FY 2019 earnings guidance on Friday, May, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $95-100 million, compared to the consensus revenue estimate of $110.87 million. Has Digirad been receiving favorable news coverage? Press coverage about DRAD stock has been trending positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Digirad earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. Who are some of Digirad's key competitors? Some companies that are related to Digirad include Viveve Medical (VIVE), Precision Optics (PEYE), Fc Global Realty (FCRE), CHF Solutions (CHFS), ENDRA Life Sciences (NDRA), Non-Invasive Monitoring Systems (NIMU), Vaso (VASO), Nexeon Medsystems (NXNN), Aradigm (ARDM), Escalon Medical (ESMC), Trimedyne (TMED), Reshape Lifesciences (RSLS), SpectraScience (SCIE), Guided Therapeutics (GTHP) and Newcardio (NWCI). What other stocks do shareholders of Digirad own? Based on aggregate information from My MarketBeat watchlists, some companies that other Digirad investors own include Novavax (NVAX), LightPath Technologies (LPTH), Prospect Capital (PSEC), Enterprise Products Partners (EPD), AT&T (T), US Stem Cell (USRM), Exelixis (EXEL), Green Plains Partners (GPP), Rigel Pharmaceuticals (RIGL) and Energy Transfer LP Unit (ET). Who are Digirad's key executives? Digirad's management team includes the folowing people: Mr. Matthew Gabel Molchan, Pres, CEO & Director (Age 52)Mr. Martin B. Shirley, Pres of Digirad Imaging Solutions (Age 57)Mr. David James Noble, COO & Interim CFO (Age 48)Mr. Bob Halbert, Sr. Director of Human Resource Who are Digirad's major shareholders? Digirad's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Weber Alan W (0.49%). Company insiders that own Digirad stock include Cannell Capital Llc, David J Noble, David James Noble, Jeffrey E Eberwein, Jeffry R Keyes, Matthew G Molchan, Michael A Cunnion and Virgil Lott. View Institutional Ownership Trends for Digirad. Which institutional investors are buying Digirad stock? DRAD stock was acquired by a variety of institutional investors in the last quarter, including Weber Alan W. Company insiders that have bought Digirad stock in the last two years include Cannell Capital Llc, David J Noble, David James Noble, Jeffrey E Eberwein, Jeffry R Keyes and Matthew G Molchan. View Insider Buying and Selling for Digirad. How do I buy shares of Digirad? Shares of DRAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Digirad's stock price today? One share of DRAD stock can currently be purchased for approximately $0.6448. How big of a company is Digirad? Digirad has a market capitalization of $13.10 million and generates $104.18 million in revenue each year. Digirad employs 452 workers across the globe. What is Digirad's official website? The official website for Digirad is http://www.digirad.com. How can I contact Digirad? Digirad's mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 30024. The medical equipment provider can be reached via phone at 858-726-1600 or via email at [email protected] MarketBeat Community Rating for Digirad (NASDAQ DRAD)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 268 (Vote Outperform)Underperform Votes: 209 (Vote Underperform)Total Votes: 477MarketBeat's community ratings are surveys of what our community members think about Digirad and other stocks. Vote "Outperform" if you believe DRAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DRAD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: 52-Week High/Low Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.